Home Tags Posts tagged with "Syngene International"

Tag: Syngene International

Overstepping the mark

The requirement to submit a test licence in the drugs and cosmetics rules goes beyond the ambit of the Parent Act, and is a hindrance to R&D for pharma companies, writes Syngene International's Shreekanth Katti

Tread carefully with TM

By Shreekanth Katti and Harry Jose, Syngene International

MOST READ ON LAW.ASIA

Who-owns-AIs-judgment

Who owns AI’s judgment?

Veteran general counsel and scientist discuss a new AI governance paradigm

Correspondents

India Healthcare Investmentvideo

Healthcare investment in India: The PE playbook

By Ayush Jain, Bharucha & Partners
Philippine Citizenship By Marriage

Bride and prejudice: Gendered paths to Philippine citizenship

By Jewel M Culala, ACCRALAW
AI investments in Indiavideo

Rethinking due diligence for Indian AI deals

By Vandana Pai and Shreya Sreesankar, Bharucha & Partners
NCLAT shields enforcement actions

PMLA free pass dilutes insolvency moratorium

By Ambar Bhushan and Divyam Sharma, Bharucha & Partners

Follow us on LinkedIn

Follow now
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.